Mortality and Its Determinants in Adult Patients with End-stage Liver Disease on Waiting List for Liver Transplantation: A Preliminary Report on Baseline Data

AuthorKamran Bagheri Lankaranien
AuthorBehnam Honarvaren
AuthorMohammad Reza Rouhezaminen
AuthorHadi Raeisi Shahrakien
AuthorVahid Seifien
AuthorBita Geramizadehen
AuthorHeshmatollah Salahien
AuthorSaman Nikeghbalianen
AuthorAlireza Shamsaeefaren
AuthorParisa Keshanien
AuthorSeyed Ali Malekhosseinien
OrcidKamran Bagheri Lankarani [0000-0002-7524-9017]en
OrcidBehnam Honarvar [0000-0002-1081-5778]en
OrcidMohammad Reza Rouhezamin [0000-0003-3231-3389]en
OrcidHadi Raeisi Shahraki [0000-0003-3071-5587]en
OrcidParisa Keshani [0000-0003-2029-992X]en
Issued Date2021-05-10en
AbstractBackground: Prevention of death in patients on the waiting list for liver transplantation (LT) is a major concern to prioritize organ allocation. Since the model for the end-stage liver disease (MELD) and its modifications have many shortages, there is a need for further refinement of the allocation strategy. Objectives: The current study aimed at assessing the predictors of mortality in LT candidates in a more comprehensive manner with the possible implications to improve the care of such patients and assist in developing better strategies for organ allocation. Methods: In the current cohort study, 544 adult LT candidates with end-stage liver disease were followed up for a mean of 12 months in three-month intervals. Data analysis was performed in Nutritionist, SPSS, and R software, using Kaplan-Meier, Cox proportional hazard (HRC), and LASSO Cox regression hazard (HRL) tests. Results: The mean age of the patients was 46.7 ± 13.7 years; the majority were male (n = 336, 61.7%). At the end of the study, 414 (76.1%) subjects were still alive and 130 (23.9%) dead. The cumulative percentages of death were 33.1%, 57.7%, and 79.2% after 3, 6, and 12 months of waiting for a donor, respectively. Although there was a strong association between having hepatopulmonary syndrome (HPS) (HRC = 4.7, HRL = 1.8), a history of myocardial infarction (MI) (HRC = 3.3, HRL = 1.6), low-carbohydrate (CHO) diet (HRC = 2.7, HRL = 1.5), and mortality, it was weak for MELD score. Moreover, a serum level of CA 125, high polymorphonuclear (PMN) count, weight loss, a high level of alanine aminotransferase (ALT), positive hepatitis B virus (HBV) markers, high mean corpuscular volume (MCV) of red blood cells, ascites, and edema of gallbladder wall had association with mortality in LT patients. Conclusions: In addition to MELD score, HPS, a history of MI, low CHO intake, weight loss, ascites, PMN, CA 125, ALT, hepatitis B surface antigen, MCV, blood urea nitrogen, and gallbladder wall thickness are predictors of mortality in LT candidates and need to be considered in the LT allocation system.en
DOIhttps://doi.org/10.5812/semj.110254en
KeywordSurvivalen
KeywordWaiting Listen
KeywordLiver Transplantationen
KeywordCirrhosis, End-stage Liver Diseaseen
PublisherBrieflandsen
TitleMortality and Its Determinants in Adult Patients with End-stage Liver Disease on Waiting List for Liver Transplantation: A Preliminary Report on Baseline Dataen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
semj-22-10-110254.pdf
Size:
329.49 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF